| Literature DB >> 31492635 |
Xu Qian1, Xinjian Li2, Zhumei Shi3, Yan Xia4, Qingsong Cai4, Daqian Xu4, Lin Tan5, Linyong Du6, Yanhua Zheng4, Dan Zhao7, Chuanbao Zhang8, Philip L Lorenzi5, Yongping You9, Bing-Hua Jiang10, Tao Jiang8, Haitao Li7, Zhimin Lu11.
Abstract
The PTEN tumor suppressor is frequently mutated or deleted in cancer and regulates glucose metabolism through the PI3K-AKT pathway. However, whether PTEN directly regulates glycolysis in tumor cells is unclear. We demonstrate here that PTEN directly interacts with phosphoglycerate kinase 1 (PGK1). PGK1 functions not only as a glycolytic enzyme but also as a protein kinase intermolecularly autophosphorylating itself at Y324 for activation. The protein phosphatase activity of PTEN dephosphorylates and inhibits autophosphorylated PGK1, thereby inhibiting glycolysis, ATP production, and brain tumor cell proliferation. In addition, knockin expression of a PGK1 Y324F mutant inhibits brain tumor formation. Analyses of human glioblastoma specimens reveals that PGK1 Y324 phosphorylation levels inversely correlate with PTEN expression status and are positively associated with poor prognosis in glioblastoma patients. This work highlights the instrumental role of PGK1 autophosphorylation in its activation and PTEN protein phosphatase activity in governing glycolysis and tumorigenesis.Entities:
Keywords: PGK1; PTEN; autophosphorylation; glycolysis; tumorigenesis
Mesh:
Substances:
Year: 2019 PMID: 31492635 DOI: 10.1016/j.molcel.2019.08.006
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970